Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy

Candace M. Adamo, Dao Fu Dai, Justin M. Percival, Elina Minami, Monte Willis, Enrico Patrucco, Stanley C. Froehner, Joseph A. Beavo

Research output: Contribution to journalArticle

111 Citations (Scopus)

Abstract

Duchenne muscular dystrophy (DMD) is a progressive and fatal genetic disorder of muscle degeneration. Patients with DMD lack expression of the protein dystrophin as a result of mutations in the X-linked dystrophin gene. The loss of dystrophin leads to severe skeletal muscle pathologies as well as cardiomyopathy, which manifests as congestive heart failure and arrhythmias. Like humans, dystrophin-deficient mice (mdx mice) show cardiac dysfunction as evidenced by a decrease in diastolic function followed by systolic dysfunction later in life. We have investigated whether sildenafil citrate (Viagra), a phosphodiesterase 5 (PDE5) inhibitor, can be used toameliorate the age-related cardiac dysfunction present in themdx mice. By using echocardiography, we show that chronic sildenafil treatment reduces functional deficits in the cardiac performance of aged mdx mice, with no effect on normal cardiac function in WT controls. More importantly, when sildenafil treatment was started after cardiomyopathy had developed, the established symptoms were rapidly reversed within a few days. It is recognized that PDE5 inhibitors can have cardioprotective effects in other models of cardiac damage, but the present studyreports a preventionand reversal of pathological cardiac dysfunction as measured by functional analysis in a mouse model of DMD. Overall, the data suggest that PDE5 inhibitors may be a useful treatment for the cardiomyopathy affecting patients with DMD at early and late stages of the disease.

Original languageEnglish (US)
Pages (from-to)19079-19083
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume107
Issue number44
DOIs
StatePublished - Nov 2 2010
Externally publishedYes

Fingerprint

Inbred mdx Mouse
Dystrophin
Duchenne Muscular Dystrophy
Phosphodiesterase 5 Inhibitors
Cardiomyopathies
X-Linked Genes
Inborn Genetic Diseases
Echocardiography
Cardiac Arrhythmias
Skeletal Muscle
Therapeutics
Heart Failure
Pathology
Muscles
Mutation
Sildenafil Citrate
Proteins

Keywords

  • Cehocardiography
  • cGMP
  • Phosphodiesterase
  • Viagra

ASJC Scopus subject areas

  • General

Cite this

Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy. / Adamo, Candace M.; Dai, Dao Fu; Percival, Justin M.; Minami, Elina; Willis, Monte; Patrucco, Enrico; Froehner, Stanley C.; Beavo, Joseph A.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 107, No. 44, 02.11.2010, p. 19079-19083.

Research output: Contribution to journalArticle

Adamo, Candace M. ; Dai, Dao Fu ; Percival, Justin M. ; Minami, Elina ; Willis, Monte ; Patrucco, Enrico ; Froehner, Stanley C. ; Beavo, Joseph A. / Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy. In: Proceedings of the National Academy of Sciences of the United States of America. 2010 ; Vol. 107, No. 44. pp. 19079-19083.
@article{fef6405abc284ac29a62fe5b4af96bd9,
title = "Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy",
abstract = "Duchenne muscular dystrophy (DMD) is a progressive and fatal genetic disorder of muscle degeneration. Patients with DMD lack expression of the protein dystrophin as a result of mutations in the X-linked dystrophin gene. The loss of dystrophin leads to severe skeletal muscle pathologies as well as cardiomyopathy, which manifests as congestive heart failure and arrhythmias. Like humans, dystrophin-deficient mice (mdx mice) show cardiac dysfunction as evidenced by a decrease in diastolic function followed by systolic dysfunction later in life. We have investigated whether sildenafil citrate (Viagra), a phosphodiesterase 5 (PDE5) inhibitor, can be used toameliorate the age-related cardiac dysfunction present in themdx mice. By using echocardiography, we show that chronic sildenafil treatment reduces functional deficits in the cardiac performance of aged mdx mice, with no effect on normal cardiac function in WT controls. More importantly, when sildenafil treatment was started after cardiomyopathy had developed, the established symptoms were rapidly reversed within a few days. It is recognized that PDE5 inhibitors can have cardioprotective effects in other models of cardiac damage, but the present studyreports a preventionand reversal of pathological cardiac dysfunction as measured by functional analysis in a mouse model of DMD. Overall, the data suggest that PDE5 inhibitors may be a useful treatment for the cardiomyopathy affecting patients with DMD at early and late stages of the disease.",
keywords = "Cehocardiography, cGMP, Phosphodiesterase, Viagra",
author = "Adamo, {Candace M.} and Dai, {Dao Fu} and Percival, {Justin M.} and Elina Minami and Monte Willis and Enrico Patrucco and Froehner, {Stanley C.} and Beavo, {Joseph A.}",
year = "2010",
month = "11",
day = "2",
doi = "10.1073/pnas.1013077107",
language = "English (US)",
volume = "107",
pages = "19079--19083",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "44",

}

TY - JOUR

T1 - Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy

AU - Adamo, Candace M.

AU - Dai, Dao Fu

AU - Percival, Justin M.

AU - Minami, Elina

AU - Willis, Monte

AU - Patrucco, Enrico

AU - Froehner, Stanley C.

AU - Beavo, Joseph A.

PY - 2010/11/2

Y1 - 2010/11/2

N2 - Duchenne muscular dystrophy (DMD) is a progressive and fatal genetic disorder of muscle degeneration. Patients with DMD lack expression of the protein dystrophin as a result of mutations in the X-linked dystrophin gene. The loss of dystrophin leads to severe skeletal muscle pathologies as well as cardiomyopathy, which manifests as congestive heart failure and arrhythmias. Like humans, dystrophin-deficient mice (mdx mice) show cardiac dysfunction as evidenced by a decrease in diastolic function followed by systolic dysfunction later in life. We have investigated whether sildenafil citrate (Viagra), a phosphodiesterase 5 (PDE5) inhibitor, can be used toameliorate the age-related cardiac dysfunction present in themdx mice. By using echocardiography, we show that chronic sildenafil treatment reduces functional deficits in the cardiac performance of aged mdx mice, with no effect on normal cardiac function in WT controls. More importantly, when sildenafil treatment was started after cardiomyopathy had developed, the established symptoms were rapidly reversed within a few days. It is recognized that PDE5 inhibitors can have cardioprotective effects in other models of cardiac damage, but the present studyreports a preventionand reversal of pathological cardiac dysfunction as measured by functional analysis in a mouse model of DMD. Overall, the data suggest that PDE5 inhibitors may be a useful treatment for the cardiomyopathy affecting patients with DMD at early and late stages of the disease.

AB - Duchenne muscular dystrophy (DMD) is a progressive and fatal genetic disorder of muscle degeneration. Patients with DMD lack expression of the protein dystrophin as a result of mutations in the X-linked dystrophin gene. The loss of dystrophin leads to severe skeletal muscle pathologies as well as cardiomyopathy, which manifests as congestive heart failure and arrhythmias. Like humans, dystrophin-deficient mice (mdx mice) show cardiac dysfunction as evidenced by a decrease in diastolic function followed by systolic dysfunction later in life. We have investigated whether sildenafil citrate (Viagra), a phosphodiesterase 5 (PDE5) inhibitor, can be used toameliorate the age-related cardiac dysfunction present in themdx mice. By using echocardiography, we show that chronic sildenafil treatment reduces functional deficits in the cardiac performance of aged mdx mice, with no effect on normal cardiac function in WT controls. More importantly, when sildenafil treatment was started after cardiomyopathy had developed, the established symptoms were rapidly reversed within a few days. It is recognized that PDE5 inhibitors can have cardioprotective effects in other models of cardiac damage, but the present studyreports a preventionand reversal of pathological cardiac dysfunction as measured by functional analysis in a mouse model of DMD. Overall, the data suggest that PDE5 inhibitors may be a useful treatment for the cardiomyopathy affecting patients with DMD at early and late stages of the disease.

KW - Cehocardiography

KW - cGMP

KW - Phosphodiesterase

KW - Viagra

UR - http://www.scopus.com/inward/record.url?scp=78650474571&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650474571&partnerID=8YFLogxK

U2 - 10.1073/pnas.1013077107

DO - 10.1073/pnas.1013077107

M3 - Article

VL - 107

SP - 19079

EP - 19083

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 44

ER -